Boron Neutron Capture Therapy
"Boron Neutron Capture Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A technique for the treatment of neoplasms, especially gliomas and melanomas in which boron-10, an isotope, is introduced into the target cells followed by irradiation with thermal neutrons.
|Boron Neutron Capture Therapy
- Boron Neutron Capture Therapy
- Therapy, Boron Neutron Capture
- Boron-Neutron Capture Therapy
- Therapy, Boron-Neutron Capture
- Neutron Capture Therapy, Boron
Below are MeSH descriptors whose meaning is more general than "Boron Neutron Capture Therapy".
Below are MeSH descriptors whose meaning is more specific than "Boron Neutron Capture Therapy".
This graph shows the total number of publications written about "Boron Neutron Capture Therapy" by people in this website by year, and whether "Boron Neutron Capture Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Boron Neutron Capture Therapy" by people in Profiles.
Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1R132H mutation-negative glioblastoma. J Neurooncol. 2017 05; 133(1):107-118.
Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapy. J Pharmacol Exp Ther. 2013 Nov; 347(2):388-97.
Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy. Neurosurgery. 2011 May; 68(5):1380-7; discussion 1387.
Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients. Appl Radiat Isot. 2009 Jul; 67(7-8 Suppl):S15-8.
Boron neutron capture therapy for newly diagnosed glioblastoma. J Radiat Res. 2009 Jan; 50(1):51-60.
Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy. J Neurooncol. 2008 May; 87(3):287-94.
Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab. Clin Cancer Res. 2007 Feb 15; 13(4):1260-8.
Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry. Radiat Res. 2007 Jan; 167(1):102-9.
Boron neutron capture therapy for recurrent malignant meningioma. Case report. J Neurosurg. 2006 Dec; 105(6):898-903.
Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT. J Neurooncol. 2006 Jul; 78(3):227-32.